Quaker BioVentures II LP - Jun 2, 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
10%+ Owner
Signature
Quaker BioVentures II, L.P. By: Quaker BioVentures Capital II, L.P., its general partner By Quaker BioVentures Capital II, LLC, its general partner By: /s/ Adele C. Oliva, Executive Manager
Stock symbol
TELA
Transactions as of
Jun 2, 2022
Transactions value $
$0
Form type
4
Date filed
6/23/2022, 06:30 AM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Other $0 -1.75M -100% $0.00* 0 Jun 2, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Quaker BioVentures II LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Quaker BioVentures II, L.P. distributed these shares on a pro rata basis, for no consideration.
F2 Quaker BioVentures Capital II, L.P., the general partner of Quaker BioVentures II, L.P., received its pro rata shares in the distribution and in turn distributed all such shares to its own partners.